4Vote!
Market Wire (Free subscription) | 07/10/2009
LONDON (MARKET WIRE) Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities. Today we began research on Pacific Capital Bancorp (NASDAQ: PCBC), Sears Holdings Corporation (NASDAQ: SHLD), Pharmaceutical Product Development Inc. (NASDAQ: PPDI), Sohu.com Inc. (NASDAQ:...
4Vote!
Market Wire (Free subscription) | 06/04/2009
LONDON (MARKET WIRE) MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in Europe. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking free research on NII Holdings Inc. (NASDAQ: NIHD), Pharmaceutical Product Development Inc. (NASDAQ: PPDI), Paragon...
3Vote!
Financial24 (Free subscription) | 04/22/2009
* Shares sink 18 pct to $17.97 * Cuts 2009 outlook April 22 - Shares of Pharmaceutical Product Development Inc fell as much as 18 percent to a four-year low Wednesday, a day after the clinic
4Vote!
MarketIntelligenceCenter.com (Free subscription) | 04/22/2009
Pharmaceutical Product Development (NasdaqNM: PPDI) hit a new 52-Week low of $17.97 so far today. Currently the stock is down $3.44 (-15.64%) to $18.55 on 5,773,899 shares traded. Today's low is down $27.17 from a 52-Week high of $45.72. Pharmaceutical Product Development stock has been showing support around $20.72 and resistance in the $23...
4Vote!
MarketIntelligenceCenter.com (Free subscription) | 03/06/2009
Pharmaceutical Product Development (NasdaqNM: PPDI) opened at $20.14. So far today, the stock has hit a low of $20.00 and a high of $22.00. PPDI is now trading at $21.56, down $1.02 (-4.52%). Over the last 52 weeks the stock has ranged from a low of $20.60 to a high of $46.70. PPDI announced this morning that it is no longer forecasting the receipt of a $25million alogliptin NDA appro...
5Vote!
SeekingAlpha.com (Free subscription) | 01/15/2009
Pharmaceutical Product Development, Inc. (PPDI) 2009 Guidance Call Complete Story »
1Vote!
Business Week (Free subscription) | 01/05/2009
) expects fourth quarter loan loss provision of about $350 million, with an estimated charge-off ratio of about 3.2%. Says largest component of these elevated charges relates to Atlanta market residential real estate credits. Also expects to increase its loan loss reserve during the quarter, and says it is assessing its goodwill for potential impairment during the fourth quarter. Morgan Keegan downgrades...
3Vote!
ireland.com (Free subscription) | 12/18/2008
US firm Pharmaceutical Product Development is expected to announce it is setting up a base at a business park in Athlone that will create 200 jobs.
4Vote!
Seeking Alpha China (Free subscription) | 10/22/2008
Start Time: 09:00 End Time: 09:56 Complete Story »
4Vote!
Market Wire (Free subscription) | 10/13/2008
LONDON (MARKET WIRE) MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for Pharmaceutical Product Development Inc. (NASDAQ: PPDI), Inergy...
4Vote!
The Earth Times Online Newspaper (Free subscription) | 10/03/2008
MADISON HEIGHTS, Mich., Oct. 3 /PRNewswire-USNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) as its December 2008 "Stoc...
1Vote!
Seeking Alpha China (Free subscription) | 07/23/2008
Pharmaceutical Product Development Inc. (PPDI) Q2 2008 Earnings Call Complete Story »
1Vote!
Seeking Alpha China (Free subscription) | 04/23/2008
Pharmaceutical Product Development Inc. (PPDI) Q1 2008 Earnings Call Complete Story »
1Vote!
The Charlotte Business Journal (Free subscription) | 04/23/2008
Pharmaceutical Product Development Inc., which recently announced plans to bring 300 private-sector jobs to the N.C. Research Campus in Kannapolis, reports first-quarter earnings of $40.1 million, or 33 cents per diluted share. (PPDI)
1Vote!
Market Watch (Free subscription) | 04/22/2008
SAN FRANCISCO (MarketWatch) -- Pharmaceutical Product Development Inc. said late Tuesday its first-quarter profit fell to $40.1 million, or 33 cents a share, from $42 million, or 35 cents a share, in the year-ago period. Excluding charges, the company would have reported a profit of 44 cents a share in the latest quarter. Revenue rose to $396.2 million from $332.3 million a year ago. Analysts surveyed...
Videos